Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, June 8, 2022 DALLAS, June 8, 2022 — Adults who survive childhood cancer have a higher risk of cardiovascular disease than the general population, yet they are 80% more likely to be undertreated for several cardiovascular risk factors: hypertension (also called high blood pressure), diabetes and high […]
Cancer
Childhood cancer survivors 80% more likely to be undertreated for cardiovascular risk factors
Adults who survive childhood cancer have a higher risk of cardiovascular disease than the general population, yet they are 80% more likely to be undertreated for several cardiovascular risk factors: hypertension (also called high blood pressure), diabetes and high cholesterol, according to new research published today in the Journal of […]
Next phases of breast cancer drug research coming to RI
PROVIDENCE, R.I. (WPRI) — Advancements in a drug targeting breast cancer growth have oncologists hopeful about potential treatment options for patients with advanced forms of the disease. Results from the DESTINY-Breast04 Phase III trial showed the intravenous drug Enhertu, also known as trastuzumab deruxtecan, demonstrated “superior and clinically meaningful” progression-free and […]
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
This research complies with all relevant ethical regulations: The Sloane project, United Kingdom National Health Service Breast Screening Programme, was approved by the UK Health Research Authority (Ethical approval REF 08/S0703/147, 19/LO/0648); The Dutch DCIS cohort study, a Netherlands Cancer Registry (NCR; reference no 12.281), nationwide network and registry of […]
Ohio House bill allows women to get more free breast cancer screenings
More Ohio women will soon have access to free additional breast cancer screenings, thanks to a few Cincinnati-area advocates and state representatives. The legislation is known as House Bill (HB) 317, and it will require insurance companies to cover additional screenings for individuals who are a high risk for breast […]
How stage 4 kidney cancer diagnosis didn’t stop this young woman from getting a great new job
Katie Coleman stood face-to-face with a choice no job seeker should ever have to make. She could tell her prospective employer she had stage 4 kidney cancer, the most life-threatening stage of all. Or she could stay mum. She knew she risked losing any shot at the job by being […]
Millions Of Women Skipped Cancer Screenings Because Of Covid Pandemic, Study Suggests
Topline The Covid-19 pandemic caused millions of women—especially Hispanic women and those with lower incomes—to forgo breast and cervical cancer screenings in 2020, according to researchers from the American Cancer Society, who suggested obstacles such as financial difficulties and broader social and economic factors during the pandemic may have played […]
Time-Restricted Eating May Reduce CVD Risk After Breast Cancer
Time-restricted eating reduced cardiovascular risk among older breast cancer survivors, a single-group feasibility study suggests. The results show a 15% relative decline in cardiovascular risk, measured using the Framingham Risk Score, among at-risk breast cancer survivors (BCS) after only 8 weeks of following a time-restricted eating regimen, reported Amy A. Kirkham, PhD, […]
Management of HR+, HER2- Early-Stage Breast Cancer After Diagnosis
Furthermore, previous analysis of the SWOG-8814 trial (NCT00929591) showed that post-menopausal women with LN involvement and an RS of 31 or more who were given chemotherapy plus tamoxifen had a survival benefit over those receiving tamoxifen alone.5 Therefore, we recommend adjuvant chemotherapy in addition to adjuvant endocrine therapy in this […]
Antibody-Drug Conjugates May Represent the Future of HER2-Low Breast Cancer Treatment
Emerging data with novel antibody-drug conjugates (ADCs) such as trastuzumab deruxtecan-nxki (Enhertu), vic-trastuzumab duocarmazine, and disitamab vedotin (Aidixi) are showing encouraging activity in HER2-low breast cancer. Paolo Tarantino, MD, said this data suggests that the classification of HER2 should go beyond merely positive or negative. “In the future, we will […]
Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancer
Adding mTOR inhibitor everolimus (Afinitor) to adjuvant endocrine therapy failed to improve disease-free survival (DFS) in high-risk hormone receptor-positive/HER2-negative (HR+/HER2-), a large randomized trial showed. Three-year DFS was 88% with everolimus plus endocrine therapy and 89% with placebo plus endocrine therapy. Tolerability figured prominently in the results, as more than […]
Patient voices a good predictor of cancer treatment outcomes — ScienceDaily
A breast cancer patient’s perspective on their physical well-being can provide a better indication of their response to cancer treatment than clinician-based tools, a new study has found, highlighting the importance of shared decision-making in the treatment process. The research also identified differences between clinician-based data and the patient-reported data, […]